Search results
AbbVie Lifts 2024 Forecast as Newer Drugs Replace Humira Losses
Bloomberg· 2 days agoAbbVie Inc. lifted its full-year profit guidance as newer anti-inflammatory treatments like Rinvoq...
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
Reuters· 3 days agoAbbVie said on Thursday its drug, Rinvoq, for treating a type of inflammatory skin condition was found to be more effective than Regeneron Pharmaceuticals and Sanofi's Dupixent in a late-stage head-to-head study.
AbbVie lifts profit forecast after Skyrizi sales beat expectations
Reuters· 2 days ago, opens new tab raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street estimates for the ...
Buying the Dip in These 3 Undervalued Dividend Stocks
Motley Fool via Yahoo Finance· 6 days agoWe have seen a stock pullback here in April, and three of these high-quality dividend paying stocks...
What is an Annuity for Retirement? 15 Dividend Stocks to Buy Instead
Insider Monkey via Yahoo Finance· 6 minutes agoIn this article, we discuss what is an annuity for retirement and 15 dividend stocks to buy instead....
AbbVie: Q1 Earnings Snapshot - WTOP News
WTOP Washington· 2 days agoNORTH CHICAGO, Ill. (AP) — NORTH CHICAGO, Ill. (AP) — AbbVie Inc. (ABBV) on Friday reported first-quarter earnings of $1.37 billion. On a per-share basis, the North Chicago…
AbbVie Inc (ABBV) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations with ...
GuruFocus.com via Yahoo Finance· 2 days agoAnd could you give us some confidence that you can continue to grow in '25 despite these headwinds from IRA and Humira? A: Robert A. Michael - AbbVie Inc. - President & COO ...
AbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up By Investing.com
Investing.com· 2 days agoAbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up
AbbVie: Q1 Earnings Snapshot
Houston Chronicle· 2 days agoOn a per-share basis, the North Chicago, Illinois-based company said it had net income of 77 cents. The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed ...
AbbVie lifts profit forecast after Skyrizi sales beat expectations
AOL· 2 days ago(Reuters) -AbbVie raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street ...
